Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions.
Ontology highlight
ABSTRACT: The Chimera antigen receptor (CAR)-T cell therapy has gained great success in the clinic. However, there are still major challenges for its wider applications in a variety of cancer types including lack of effectiveness due to the highly complex tumor microenvironment, and the forbiddingly high cost due to the personalized manufacturing procedures. In order to overcome these hurdles, numerous efforts have been spent focusing on optimizing Chimera antigen receptors, engineering and improving T cell capacity, exploiting features of subsets of T cell or NK cells, or making off-the-shelf universal cells. Here, we developed induced pluripotent stem cells (iPSCs)-derived, CAR-expressing macrophage cells (CAR-iMac). CAR expression confers antigen-dependent macrophage functions such as expression
SUBMITTER: Zhang L
PROVIDER: S-EPMC7656711 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA